From October 1, 2022 to December 30, 2022, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 3,909,896 shares, representing 0.45% for CNY 369.4 million under the buyback announced on February 13, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
48.6 CNY | -0.12% | -4.89% | -11.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.59% | 5.4B | |
+22.10% | 46.55B | |
+47.13% | 41.84B | |
-3.12% | 40.84B | |
+36.10% | 32.95B | |
-6.30% | 28.27B | |
+18.71% | 27.78B | |
+46.15% | 14.26B | |
+44.52% | 13.69B | |
+0.19% | 12.18B |
- Stock Market
- Equities
- 300347 Stock
- News Hangzhou Tigermed Consulting Co., Ltd
- Tranche Update on Hangzhou Tigermed Consulting Co., Ltd.'s Equity Buyback Plan announced on February 13, 2022.